Please login to the form below

Not currently logged in
Email:
Password:

financial results 2012

This page shows the latest financial results 2012 news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs OTC use of Sanofi's allergy drug

FDA panel backs OTC use of Sanofi's allergy drug

Profits have declined since 2008, however, when Teva and Barr Pharmaceuticals won a patient challenge to launch their own generic copy, and Nasacort AQ achieved revenues of just 71m during 2012 ... This is part of a wider plan to build its consumer

Latest news

More from news
Approximately 17 fully matching, plus 6 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....